Zobrazeno 1 - 10
of 62
pro vyhledávání: '"IA Jagroop"'
Publikováno v:
Current Pharmaceutical Design. 13:1669-1683
Epidemiological studies have linked platelet hyperactivity with an increased risk of vascular events. Even more convincing is the evidence from appropriately designed clinical trials showing that antiplatelet agents decrease the risk of vascular even
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 14(1)
The mechanism of thrombogenicity in hyperhomocysteinemia remains controversial. The authors investigated the association between elevated plasma homocysteine levels, platelet function, and blood coagulation. Blood was collected from healthy subjects
Autor:
Dimitri P. Mikhailidis, IA Jagroop
Publikováno v:
Journal of human hypertension. 14(9)
Platelet shape change (PSC) is an early phase of platelet activation that precedes platelet aggregation. This phase of platelet activation is essentially aspirin resistant. PSC was monitored, by measuring the median platelet volume (MPV) using a high
Autor:
Dimitri P. Mikhailidis, IA Jagroop
Publikováno v:
Journal of human hypertension. 15(3)
Patients with peripheral vascular disease or diabetes mellitus tend to have elevated circulating levels of naturally occurring platelet agonists like serotonin (5 hydroxytryptamine; 5-HT). This bioamine can induce platelet shape change (PSC) an early
Autor:
Dimitri P. Mikhailidis, IA Jagroop
Publikováno v:
Journal of internal medicine. 244(2)
Autor:
Jagroop IA; Academic Department of Surgery, Division of Surgical and Interventional Science, Royal Free Campus, University College London Medical School, University College London (UCL), Pond Street, London, NW3 2QG, UK, indera.jagroop@ucl.ac.uk.
Publikováno v:
Purinergic signalling [Purinergic Signal] 2014; Vol. 10 (2), pp. 233-9. Date of Electronic Publication: 2013 Nov 05.
Autor:
Jagroop IA, Mikhailidis DP
Publikováno v:
Thrombosis research [Thromb Res] 2012 Oct; Vol. 130 (4), pp. 685; author reply 686. Date of Electronic Publication: 2012 Jul 20.
Autor:
Jagroop IA; Department of Surgery, Division of Surgical and Interventional Science, Royal Free campus, University College London Medical School, University College London, London, UK., Persaud JW, Mikhailidis DP
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2011 Nov-Dec; Vol. 17 (6), pp. 578-84. Date of Electronic Publication: 2011 Apr 12.
Autor:
Jagroop IA; Department of Clinical Biochemistry, Royal Free University College School of Medicine, University College London, University of London, Royal Free Hospital Campus, London, UK., Mikhailidis DP
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2008 Jul; Vol. 14 (3), pp. 295-302. Date of Electronic Publication: 2008 Apr 28.
Autor:
Mohan IV; Academic Surgical Unit, Imperial College at St Mary's, London, UK. irwin.mohan@doctors.org.uk, Jagroop IA, Mikhailidis DP, Stansby GP
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2008 Jan; Vol. 14 (1), pp. 8-18. Date of Electronic Publication: 2007 Dec 26.